BGNE BeOne Medicines: Bozor kapitallashuvining balans qiymatiga nisbati

BeOne Medicines (BGNE) - korporativ logo

GURU.Markets terminalining chiziqli grafigidagi kompaniyaning bozor qiymatining uning balans aktivlariga nisbati joriy dinamikani namoyish etmoqda, bunda 8.21 ko'rsatkichning joriy qiymatidir. O'sish BeiGene, Ltd. (BGNE) kompaniyasining global saraton immunoterapiyasi segmentidagi kengayishi hisobiga yuz bermoqda. Istiqbollar barqaror dori sintezi usullarini joriy etishga va tadqiqot va ishlanmalar (R&D) xarajatlarini muvaffaqiyatli qoplaydigan barqaror likvidlikka bog'liq.

BeiGene, Ltd. (BGNE) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 29.10.2026gacha

BGNE (BeiGene Ltd.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi BeiGene, Ltd.|BGNE - Oʻrtacha prognoz narxi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi BeOne Medicines|BGNE - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati BeiGene|BGNE - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati beigene.com|BGNE - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati BeiGene, Ltd.|BGNE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati BeOne Medicines|BGNE - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati BeOne Medicines|BGNE - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari BeiGene
Fundamental baholash:BGNE (BeiGene, Ltd.)
BeiGene Ltd. tayyor mahsulotlari

Ushbu ko'rsatkich bozor qiymatining sof aktivlar qiymatiga nisbati sifatida hisoblanadi va kelajakdagi o'sish uchun qo'shimcha qiymatni aks ettiradi. U biznesning moddiy aktivlar bazasiga nisbatan qanchalik hadda qimmat baholanganini o'lchaydi. BeiGene, Ltd. (BGNE) kompaniyasida AI platformalari va robotlashtirilgan bioskrinning joriy etilishi tadqiqot va ishlanmalar (R&D) samaradorligini oshiradi va kapitalning yuqori xarajatlarini oqlaydi. Bozor qiymatining sof aktivlar qiymatiga nisbatidagi barqaror tendentsiya bozorning kompaniyaning texnologik ustunligiga bo'lgan ishonchini tasdiqlaydi. Ushbu trayektoriya investitsiyalarning to'xtab qolish xavfini baholash imkonini beradi.

Asosiy raqobatchilar

Bozor kapitallashuvining balans qiymatiga nisbati ONC|halozyme.com (HALO) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Protara Therapeutics - Kapitallashuvning sof aktivlarga nisbati|FATE: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aadibio.com WHWK|TScan Therapeutics, Inc. (TCRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CSBR (Champions Oncology Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBiotech USA|Bozor kapitallashuvining balans qiymatiga nisbati CEL-SCI Corporation (CVM)|Bozor qiymatining balans qiymatiga nisbati ostherapies.com (OSTX)|RADX: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Artiva Biotherapeutics Inc. ARTV|Bozor kapitallashuvining balans qiymatiga nisbati ANL (Adlai Nortye Limited)|VERU - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati TPST (Tempest Therapeutics)|Xilio Therapeutics (XLO) - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RENB (Renovaro Biosciences)|Bozor qiymatining balans qiymatiga koeffitsiyenti MURA|Bozor qiymatining balans qiymatiga nisbati Kairos Pharma Ltd KAPA|Kapitallashuvning balans qiymatiga nisbati onkuretherapeutics.com (OKUR)|GDTC: Bozor kapitallashuvining balans qiymatiga nisbati|CRIS - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Apollomics Corp (APLM)|THAR: Balans qiymatiga nisbatan bozor qiymati|advanbiomed.com (ADVB) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Genprex Inc|Calidi Biotherapeutics Inc. (CLDI) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori sunshinebiopharma.com|Bozor kapitallashuvining balans qiymatiga nisbati Xenetic Biosciences XBIO|Kapitallashuvning balans qiymatiga nisbati Salarius Pharmaceuticals Inc SLRX|Kapitallashuvning sof aktivlarga nisbati PPBT|Balans qiymatiga nisbatan bozor kapitallashuvi American Oncology Network Inc AONC|CKPT - Bozor kapitallashuvining balans qiymatiga nisbati|ELEV - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ICAD (icadmed.com)|IKNA (Ikena Oncology) - Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati Notable Labs Inc. (NTBL)|Kapitallashuvning balans qiymatiga nisbati Viracta|MorphoSys AG - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti nayabiosciences.com (NAYA)|Ascentage Pharma - Bozor kapitallashuvining balans qiymatiga nisbati